FDA Approved: CISPLATIN — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for cisplatin filed by Fresenius Kabi USA, LLC. This action confirms the continued approval of cisplatin under the suppl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervical Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Small Cell Lung Cancer
• Testicular Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

SUPPL AP for CISPLATIN (CISPLATIN)